Lawsuit disputes claims of popular memory loss supplement
A government lawsuit seeks to ban a popular memory loss dietary supplement marketed to seniors, saying there's no scientific evidence to support its claims.
Jan 9, 2017
0
1
A government lawsuit seeks to ban a popular memory loss dietary supplement marketed to seniors, saying there's no scientific evidence to support its claims.
Jan 9, 2017
0
1
Do you take time to read the risk warnings on drug websites before you take the drug?
Oct 12, 2016
0
0
New York state has launched an antitrust probe into Mylan's sale of the EpiPen anti-allergy injector to local school systems, New York's attorney general announced Tuesday.
Sep 6, 2016
0
3
The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues—and looming competition threatens its near-monopoly.
Aug 29, 2016
0
0
Israeli drugmaker Teva, the largest generic drug company in the world, said Wednesday it expects to complete its $40.5 billion purchase of the generic drug business of competitor Allergan next week after federal regulators ...
Jul 27, 2016
0
5
It was definitely déjà vu in the media today. Reuters, The New Yorker, Los Angeles Times, and more were back on the "brain training prevents dementia" bandwagon.
Jul 26, 2016
0
14
An appeal to emotions like excitement or anger is a key persuasion tactic used by fraudsters to mislead the elderly.
May 4, 2016
0
5
A new survey finds that homeopathic medicines are primarily used by a small segment of the U.S. population for common, self-limited conditions such as the common cold or back pain. The report published in the American Journal ...
Feb 18, 2016
0
11
Universal Health Services, one of the largest hospital operators in the U.S., said Friday it will buy addiction treatment facility company Foundations Recovery Network for $350 million.
Sep 18, 2015
0
6
Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September.
Aug 24, 2015
0
10